Skip to content

Fusion Ultrasound for Diagnosis and Monitoring of Endometriosis Lesions

Fusion Ultrasound for Diagnosis and Monitoring of Endometriosis Lesions ENDOFUSION

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04554602
Acronym
ENDOFUSION
Enrollment
24
Registered
2020-09-18
Start date
2021-03-01
Completion date
2026-12-31
Last updated
2024-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

The aim of the study is evaluate the fusion ultrasound performance compared to MRI and coelioscopy diagnosis when a surgical intervention is performed.

Detailed description

The research is about diagnosis performance between fusion ultrasound and the gold standard (MRI coelioscopy ). Fusion ultrasound is a no-invasive scientific technical which allow with security to evaluate the progress of endometriosis lesions. During 39 months, 200 patients will be follow. In one arm, there is the control group with women without endometriosis. In the second arm, there is the patient with endometriosis. We will compare monitoring differences between gold standard and fusion ultrasound ( Cost assessment,exams duration, reproductibility, the link between symptoms and evolution of the lesion size).

Interventions

DIAGNOSTIC_TESTFusion ultrasound

Fusion ultrasound is a technique that allows a volume acquired in MRI to be coupled to an ultrasound scan with real-time image synchronisation.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients from 18 to 50 years old * Patient informed and who gave her non-opposition to participate in the research * Patient with an indication for pelvic MRI and pelvic ultrasound either for the exploration of endometriosis or pelvic pain, or for another gynaecological pathology (ovarian cyst, poly-myomatous uterus, uterine malformation) outside of a proven cancer indication. * Patient affiliated to a social security or entitled to a social security allowance

Exclusion criteria

* Patient with a proven cancerous pathology at the time of the prescription of the complementary examinations. * Virgin patient * Pregnant patient * Patients under protective measures * Contraindication to MRI (claustrophobia, intracorporeal metallic foreign body)

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity, specificity, positive predictive value (VPP) and negative predictive value (VPN) of fusion ultrasound compared to transvaginal ultrasound and MRI for the diagnosis of endometriosis lesions3 years and 3 monthsTo evaluate the diagnostic performance of fusion ultrasound compared to transvaginal gynaecological ultrasound and MRI for the diagnosis of endometriosis lesions.

Secondary

MeasureTime frameDescription
Evaluate the reproducibility of the conclusions of the fusion ultrasound between 2 operators.3 years and 3 monthsEvaluation of the reproducibility by an intra-class correlation test for the conclusions of fusion ultrasound between two operators.
To evaluate the contribution of fusion ultrasound in the follow-up of patients suffering from endometriosis, in particular with an ultrasound follow-up in comparison with an initial reference MRI in the case of medical or surgical management.3 years and 3 monthsCorrelation between the evolution of clinical and quality of life symptoms (EHP30 form and Short Form 36) and the evolution of lesion size between initial MRI and follow-up ultrasounds at 6 months and one year
Compare the duration of a standard ultrasound scan to an ultrasound scan with fusion3 years and 3 monthsComparison of the average examination time by a Student T-test between standard and fusion ultrasound.
Evaluation of the cost of imaging for 3 years between an annual fusion ultrasound surveillance in replacement of a annual MRI surveillance3 years and 3 monthsComparison of imaging costs will be carried out over 3 years between a conventional procedure with annual MRI and the procedure being evaluated

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026